Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

NCT05460533

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Stanford University (Data Collection Only) Stanford, California, United States
  • Children's Hospital Colorado (Data Collection Only) Aurora, Colorado, United States
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

NCT05043922

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations
  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, China
  • The Southwest Hospital of AMU Chongqing, China
View all 36 locations
View Trial Details
Active, Not Recruiting

Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

NCT06054113

Conditions
B Precursor Acute Lymphoblastic Leukemia, Disease Attributes, Pathologic Processes, +3 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Childrens Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Wuhan Childrens Hospital Wuhan, Hubei, China
View Trial Details
Active, Not Recruiting

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

NCT02718833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
  • Newton-Wellesley Hospital Newton, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.

NCT06359002

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Het Ziekenhuisnetwerk Antwerpen Antwerp, Belgium
  • UZ Leuven Leuven, Belgium
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
  • Institut Catala d'Oncologia Badalona, Spain
View Trial Details
Active, Not Recruiting

Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome

NCT02670525

Conditions
Disease Attributes, Matched Targeted Therapy, Pathologic Processes, +3 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma

NCT06079164

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Henry-Joyce Cancer Clinic Nashville, Tennessee, United States
  • St. David's South Austin Medical Center Austin, Texas, United States
View Trial Details
Active, Not Recruiting

Lamivudine for Solid Tumors

NCT06494579

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details

Related conditions